Revisión sistemática de la loperamida: No hay pruebas de que los antibióticos sean superiores a la loperamida en el tratamiento de la diarrea de viajeros leves / moderados.

Categoría Revisión sistemática
RevistaTravel medicine and infectious disease
Año 2016

Este artículo está incluido en 1 Síntesis amplia 28 Síntesis amplias (1 referencia)

Este artículo incluye 28 Estudios primarios 28 Estudios primarios (28 referencias)

Este artículo es parte de las siguientes matrices de evidencia
Cargando información sobre las referencias
Looking at the worldwide emergency of antimicrobial resistance, international travellers appear to have a central role in spreading the bacteria across the globe. Travellers' diarrhoea (TD) is the most common disease encountered by visitors to the (sub)tropics. Both TD and its treatment with antibiotics have proved significant independent risk factors of colonization by resistant intestinal bacteria while travelling. Travellers should therefore be given preventive advice regarding TD and cautioned about taking antibiotics: mild or moderate TD does not require antibiotics. Logical alternatives are medications with effects on gastrointestinal function, such as loperamide. The present review explores literature on loperamide in treating TD. Adhering to manufacturer's dosage recommendations, loperamide offers a safe and effective alternative for relieving mild and moderate symptoms. Moreover, loperamide taken singly does no predispose to contracting MDR bacteria. Most importantly, we found no data that would show antibiotics to be significantly more effective than loperamide in treating TD.
Epistemonikos ID: 005df5d0cc68b80d76afe9f1060e44397939e39a
First added on: Jul 06, 2016